Key result
The Framingham Heart Study continues to provide important longitudinal information on human cardiovascular physiology and major risk factors for cardiovascular disease.
Why the study?
This paper provides an overview of the cohorts, collected data, and major research findings to date of the Framingham Heart Study.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Prior to Framingham we understood relatively little about causal factors related to heart disease and we knew even less about things you could do to prevent it.”
“It's a very strong message of prevention and hope. This tells us that better health care access, preventive measures, smoking cessation and better treatment of high blood pressure and cholesterol may be helpful in lowering the lifetime probability of developing a heart attack or a stroke.”
“Over decades, the Framingham Heart Study has produced great learnings that further our understanding of cardiovascular disease in America.”
Supports risk factor monitoring; extends observational data but leaves causal effects and practice change open.
The Framingham Heart Study is the longest-running cardiovascular epidemiological study, starting in 1948. This paper gives an overview of the various cohorts, collected data, and most important research findings to date. In brief, the Framingham Heart Study, funded by the National Institutes of Health and managed by Boston University, spans 3 generations of well phenotyped White persons and 2 cohorts comprised of racial and ethnic minority groups. These cohorts are densely phenotyped, with extensive longitudinal follow-up, and they continue to provide us with important information on human cardiovascular and noncardiovascular physiology over the lifespan, as well as to identify major risk factors for cardiovascular disease. This paper also summarizes some of the more recent progress in molecular epidemiology and discusses the future of the study.
No takes yet. Share an insight, caveat, or question.
Andersson et al. (2021) conducted a review in Cardiovascular disease. Cardiovascular risk factors was evaluated. The Framingham Heart Study continues to provide important longitudinal information on human cardiovascular physiology and major risk factors for cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: